Left Ventricular Assist Device Therapy in Cold and Dry Patients

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• End-stage heart failure patients with low pulmonary capillary wedge pressure are termed "cold and dry."
• This subgroup is understudied, and the benefits of left ventricular assist device (LVAD) therapy remain unclear.
• Understanding their outcomes is crucial for optimizing mechanical circulatory support strategies.

Purpose of the Study:

• To compare the outcomes of "cold and dry" versus "cold and wet" patients undergoing LVAD implantation.
• To evaluate the impact of LVADs on survival, functional capacity, and quality of life in these distinct patient groups.

Main Methods:

• Analysis of adult LVAD recipients (2006-2017) from the Interagency Registry for Mechanically Assisted Circulatory Support database.
• Classification into "cold and wet" (pulmonary capillary wedge pressure >15 mm Hg) and "cold and dry" (pulmonary capillary wedge pressure ≤15 mm Hg) based on pre-LVAD hemodynamics.
• Primary outcome: 1-year survival; secondary outcomes: rehospitalizations, functional capacity (6-minute walk test), and quality of life (Kansas City Cardiomyopathy Questionnaire, EuroQol questionnaire).

Main Results:

• The study included 10,310 patients; "cold and dry" patients (15% of cohort) had better baseline renal function, functional capacity, and quality of life.
• While both groups showed improvements post-LVAD, "cold and dry" patients experienced milder gains in quality of life and functional capacity.
• No significant differences were observed in 1-year hospitalizations, adverse events, or mortality between the "cold and dry" and "cold and wet" groups.

Conclusions:

• LVAD therapy provides significant, albeit milder, improvements in functional capacity and quality of life for "cold and dry" end-stage heart failure patients.
• Survival and adverse event rates at 1 year are comparable between "cold and dry" and "cold and wet" LVAD recipients.
• These findings highlight the importance of individualized treatment approaches for heart failure patients based on hemodynamic profiles.